Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients

Detalhes bibliográficos
Autor(a) principal: Machado, Mariana
Data de Publicação: 2023
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/63065
Resumo: © 2023 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
id RCAP_8fb80ae4ec4cb1dd6f7158184715118c
oai_identifier_str oai:repositorio.ul.pt:10451/63065
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients© 2023 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)Liver cancer is in the top three leading causes of death from cancer worldwide. Hepatocellular carcinoma (HCC) accounts for 85% of primary liver cancers and develops in patients with chronic liver disease (CLD). The progressive increase in the prevalence of nonalcoholic fatty liver disease (NAFLD), which recently reached up to 30% of the global population, and the recent effective treatment for hepatitis C, results in NAFLD being the most rapidly increasing etiology for HCC. Since the beginning of the millennium, the proportion of NAFLD-attributable HCC increased up to 8-fold, currently accounting for 15% of HCC cases.ElsevierRepositório da Universidade de LisboaMachado, Mariana2024-03-01T11:38:39Z20232023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/63065engAnn Hepatol. 2023 May-Jun;28(3):1011011665-268110.1016/j.aohep.2023.1011012659-5982info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-04T01:21:17Zoai:repositorio.ul.pt:10451/63065Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:12:34.790827Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
title Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
spellingShingle Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
Machado, Mariana
title_short Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
title_full Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
title_fullStr Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
title_full_unstemmed Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
title_sort Hepatocellular carcinoma screening in NAFLD: the paradox of nearly half the cases arising in non-cirrhotic low risk patients
author Machado, Mariana
author_facet Machado, Mariana
author_role author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Machado, Mariana
description © 2023 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
publishDate 2023
dc.date.none.fl_str_mv 2023
2023-01-01T00:00:00Z
2024-03-01T11:38:39Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/63065
url http://hdl.handle.net/10451/63065
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Ann Hepatol. 2023 May-Jun;28(3):101101
1665-2681
10.1016/j.aohep.2023.101101
2659-5982
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137774998126592

Registros relacionados